title: [Intra-arterial infusion chemotherapy with [Sar1, Ile8] angiotensin II in bladder cancer].
abstract: Twenty patients with bladder cancer were treated with intra-arterial infusion chemotherapy using CDDP and ADM in combination with [Sar1, Ile8] angiotensin II. A catheter was introduced into internal iliac artery by Seldinger's technique, and 100 mg of CDDP, 50 mg of ADM and 1 mg of [Sar1, Ile8] angiotensin II were infused through the catheter for 40 minutes. CR was observed in 8 of 20 patients. PR in 11 and NC in 1. Therefore, the response rate (CR + PR) was 95% (19/20). Side effects were generally mild and consisted of leukopenia, nausea, vomiting, diarrhea, alopecia, skin pigmentation and headache. Catheter-related complications were not observed. This study demonstrated that intra-arterial infusion chemotherapy with CDDP and ADM in combination with [Sar1, Ile8] angiotensin II was extremely effective in treating patients with bladder cancer.
authors: Dept. of Urology, Jichi Medical School, Tochigi, Japan.
authors: T
authors: T
authors: Morita
authors: T
authors: T
authors: Kikuchi
authors: Y
authors: Y
authors: Hara
authors: S
authors: S
authors: Ishikawa
authors: Y
authors: Y
authors: Kobayashi
authors: S
authors: S
authors: Ishiyama
authors: K
authors: K
authors: Tozuka
authors: K
authors: K
authors: Goto
authors: N
authors: N
authors: Nakashima
authors: K
authors: K
authors: Takahashi
mesh_terms: D015059:1-Sarcosine-8-Isoleucine Angiotensin II / Q000008:administration & dosage / Q000009:adverse effects; D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000505:Alopecia / Q000139:chemically induced; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000097:blood / Q000188:drug therapy; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D001749:Urinary Bladder Neoplasms / Q000097:blood / Q000188:drug therapy*
chemical_list: D004317:Doxorubicin; D015059:1-Sarcosine-8-Isoleucine Angiotensin II; D002945:Cisplatin